Search for Video Filter by category
Date Added Most Popular
All Videos Educational Technical Support Products Customer
AGBT 2013 Five perspectives on the meeting

86 views | 1 decade ago

Loading the Tumor/Normal Sequencing Data into the Broad IGV

415 views | 1 decade ago

This video shows how to load the Tumor/Normal Sequencing Project dataset into the Broad IGV, how to load the files within this project for visualization, and provides a brief orientation to allow navigation...

What Does the Somatic Summary Report Show?

684 views | 1 decade ago

This video reviews the findings reported in the Somatic Summary Report which is produced following Tumor/Normal sequencing data analysis by the Cancer Sequencing Workflow.

Innovation Through Collaboration

183 views | 1 decade ago

Hear about Illumina's collaborative approach to developing TruSight content sets.

The Belnap Family Diagnostic Odyssey

138 views | 1 decade ago

The Belnap family discuss their diagnostic odyssey

Seeking incremental improvements, excellent clinical science

88 views | 1 decade ago

Richard Moore, British Columbia Cancer Agency A frequent attendee at AGBT, Dr. Moore from the Vancouver's Michael Smith Genome Sciences Centre seeks to learn about incremental and platform improvements...

Improving next-gen sequencing library prep

466 views | 1 decade ago

Paolo Piazza, The Wellcome Trust Centre for Human Genetics As the supervisor of the library prep team in a core facility, Dr. Piazza is finding better solutions for their research partners and unique...

Inspired by the science and networking opportunities

305 views | 1 decade ago

Jennifer Fettweis, Virginia Commonwealth University A post-doctoral fellow and first-time AGBT attendee, Dr. Fettweis is working on the human vaginal microbiome project, and is excited by the caliber...

For Research Use Only

Not for use in diagnostic procedures (except as specifically noted).

Innovative technologies

At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. It is mission critical for us to deliver innovative, flexible, and scalable solutions to meet the needs of our customers. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and providing the highest level of quality, we strive to meet this challenge. Illumina innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics.

All trademarks are the property of Illumina, Inc. or their respective owners.
For specific trademark information, see sapac.illumina.com/company/legal.html.

© 2024 Illumina, Inc. All rights reserved.